StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research report released on Wednesday morning. The firm issued a sell rating on the medical technology company’s stock.
BIOLASE Stock Down 7.7 %
Shares of BIOLASE stock opened at $0.01 on Wednesday. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94. The stock has a market cap of $300,663.00, a P/E ratio of 0.00 and a beta of 0.67. The business’s 50 day moving average is $0.01 and its 200-day moving average is $0.02.
About BIOLASE
Featured Stories
- Five stocks we like better than BIOLASE
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Investing in Construction Stocks
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Short Selling – The Pros and Cons
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.